SRTA Q3'26 Earnings: EPS estimate is (0.01) USD

What happened

Strata Critical Medical, Inc. is scheduled to announce Q3 2026 results on November 3 before the market opens, with disclosure expected at 9:30 a.m. ET. The supplied estimate is revenue of 72.67 million USD and earnings per share, or profit or loss allocated to each share, of negative 0.01.

Confirmed

Global impact / market context

The figures are expectations, not reported results. If actual revenue or earnings differ, investors may reassess the company’s sales trajectory and losses, potentially changing its share valuation. The article provides no guidance on cash available, costs, or the reasons behind the estimates.

Analyst inference

The article lists earlier quarterly revenue estimates and reported figures, but it does not provide a complete comparison for Q3 2026. Investors can compare the forthcoming results with the stated revenue and negative earnings-per-share estimates; a revenue or per-share earnings miss could weaken expectations for sales or profitability.

Analyst inference

What to watch

1. Check the November 3 release for actual revenue against the stated estimate; a shortfall or beat could alter expectations for the company’s sales trajectory. Proposed
2. Compare reported earnings per share with the stated negative estimate, and note any company explanation of costs or the factors behind the result. Proposed
3. Look for management guidance on upcoming sales, costs, and cash available; changes there could shape expectations for future results and the company’s funding needs. Analyst inference

Evidence

• Original source link unavailable